Influence of early discovery safety on eliminating off-target insulin receptor activity and selection of the candidate drug AZD9291
2014; Elsevier BV; Volume: 229; Linguagem: Inglês
10.1016/j.toxlet.2014.06.221
ISSN1879-3169
AutoresMark J. Anderton, Richard J. Ward, Anne Galer, Darren A.E. Cross, Louise Marks, Ray Finlay,
Tópico(s)Pharmaceutical studies and practices
Referência(s)